AREDS2 stands for Age-Related Eye Disease Study 2, a clinical trial conducted by the National Eye Institute. The study found that a specific combination of vitamins and minerals could help reduce ...

Participants in the AREDS2 study took one of four AREDS2 supplement formulations identified as potentially beneficial in the AREDS study. Each participant took the supplement daily for five years.

Inspired by the AREDs-2 study and enriched with antioxidant-rich plant extracts like bilberry, turmeric, saffron, and ginkgo biloba, iGenics targets the root causes of declining vision—oxidative ...

At the end of the five-year AREDS2 study period, the researchers concluded that lutein and zeaxanthin did not increase risk for lung cancer, and that the new formation could reduce the risk of AMD ...

The Age-Related Eye Disease Study 2 (AREDS2) formula of vitamins and minerals remains safe and effective in treating age-related macular degeneration (AMD) over 10 years, researchers say.

The benefits of the formulation were confirmed in the National Eye Institute’s Age-Related Eye Disease Study (AREDS 2) study, which followed 3,883 individuals with moderate to advanced AMD over ...

Another smart move, especially for those with wet stage AMD, according to the National Eye Institute AREDs 2 study: Slow progression of dry AMD with a daily supplement formula. The supplements ...